KRYSTAL LIMB: Open Payments
NPI 1952025579 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 31 payments from 15 companies in 2025. Trend: 2023 $67 · 2024 $0 · 2025 $911
Food & beverage: $895Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $366 |
| Kowa Pharmaceuticals America, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 6 | $108 |
| Dexcom, Inc. | 1 | $78 |
| Exact Sciences Corporation | 2 | $31 |
| ABBVIE INC. | 1 | $28 |
| Lilly USA, LLC | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
Products named: Ozempic, ZORYVE, DEXCOM G7 GSS (161), BREZTRI, Cologuard Collection Kit, FARXIGA, QULIPTA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
